Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.

@article{Honecker2002PhaseIS,
  title={Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.},
  author={Friedemann Honecker and Christian K. Kollmannsberger and D. Quietzsch and Cornelie Haag and Michael Schroeder and C Spott and Joerg Thomas Hartmann and W Baronius and Von C. G. Hempel and Lothar Kanz and C Carsten Bokemeyer},
  journal={Anti-cancer drugs},
  year={2002},
  volume={13 5},
  pages={497-503}
}
The aim of this study was to evaluate the toxicity and efficacy of combination chemotherapy with weekly 24-h continuous infusion of 5-fluorouracil (5-FU)/folinic acid, weekly paclitaxel and 3-weekly cisplatin in patients with unresectable, locally advanced or metastatic gastric adenocarcinoma. Between November 1999 and November 2001, 29 chemotherapy-naive… CONTINUE READING